BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21875564)

  • 1. Chemical stress on protein disulfide isomerases and inhibition of their functions.
    Imaoka S
    Int Rev Cell Mol Biol; 2011; 290():121-66. PubMed ID: 21875564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate recognition by the protein disulfide isomerases.
    Hatahet F; Ruddock LW
    FEBS J; 2007 Oct; 274(20):5223-34. PubMed ID: 17892489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein disulfide isomerase modification and inhibition contribute to ER stress and apoptosis induced by oxidized low density lipoproteins.
    Muller C; Bandemer J; Vindis C; Camaré C; Mucher E; Guéraud F; Larroque-Cardoso P; Bernis C; Auge N; Salvayre R; Negre-Salvayre A
    Antioxid Redox Signal; 2013 Mar; 18(7):731-42. PubMed ID: 23083489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures and functions of protein disulfide isomerase family members involved in proteostasis in the endoplasmic reticulum.
    Okumura M; Kadokura H; Inaba K
    Free Radic Biol Med; 2015 Jun; 83():314-22. PubMed ID: 25697777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
    Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
    Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isomerase and chaperone activities of protein disulfide isomerase are both required for its function as a foldase.
    Wang CC
    Biochemistry (Mosc); 1998 Apr; 63(4):407-12. PubMed ID: 9556523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacitracin is not a specific inhibitor of protein disulfide isomerase.
    Karala AR; Ruddock LW
    FEBS J; 2010 Jun; 277(11):2454-62. PubMed ID: 20477872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein disulfide-isomerase, a folding catalyst and a redox-regulated chaperone.
    Wang L; Wang X; Wang CC
    Free Radic Biol Med; 2015 Jun; 83():305-13. PubMed ID: 25697778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacitracin inhibits the reductive activity of protein disulfide isomerase by disulfide bond formation with free cysteines in the substrate-binding domain.
    Dickerhof N; Kleffmann T; Jack R; McCormick S
    FEBS J; 2011 Jun; 278(12):2034-43. PubMed ID: 21481187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule probe suitable for in situ profiling and inhibition of protein disulfide isomerase.
    Ge J; Zhang CJ; Li L; Chong LM; Wu X; Hao P; Sze SK; Yao SQ
    ACS Chem Biol; 2013 Nov; 8(11):2577-85. PubMed ID: 24070012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of protein disulfide isomerase as a therapeutic drug target.
    Khan MM; Simizu S; Kawatani M; Osada H
    Oncol Res; 2011; 19(10-11):445-53. PubMed ID: 22715587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein disulfide isomerases from C. elegans are equally efficient at thiol-disulfide exchange in simple peptide-based systems but show differences in reactivity towards protein substrates.
    Karala AR; Psarrakos P; Ruddock LW; Klappa P
    Antioxid Redox Signal; 2007 Nov; 9(11):1815-23. PubMed ID: 17711389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oxidoreductase behavior of protein disulfide isomerase impedes fold maturation of endoplasmic reticulum-processed proteins in the pivotal structure-coupled step of oxidative folding: implications for subcellular protein trafficking.
    Gonzalez V; Pal R; Narayan M
    Biochemistry; 2010 Jul; 49(29):6282-9. PubMed ID: 20568731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein disulfide isomerase: a promising target for cancer therapy.
    Xu S; Sankar S; Neamati N
    Drug Discov Today; 2014 Mar; 19(3):222-40. PubMed ID: 24184531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-denatured Green Fluorescent Protein (GFP) as model substrate to study the chaperone activity of protein disulfide isomerase.
    Mares RE; Meléndez-López SG; Ramos MA
    Int J Mol Sci; 2011; 12(7):4625-36. PubMed ID: 21845100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thioredoxin superfamily in oxidative protein folding.
    Lu J; Holmgren A
    Antioxid Redox Signal; 2014 Jul; 21(3):457-70. PubMed ID: 24483600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERp57 and PDI: multifunctional protein disulfide isomerases with similar domain architectures but differing substrate-partner associations.
    Maattanen P; Kozlov G; Gehring K; Thomas DY
    Biochem Cell Biol; 2006 Dec; 84(6):881-9. PubMed ID: 17215875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the ERO1-PDI interaction in oxidative protein folding and disease.
    Shergalis AG; Hu S; Bankhead A; Neamati N
    Pharmacol Ther; 2020 Jun; 210():107525. PubMed ID: 32201313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPW-RX40 prevents human platelet activation by attenuating cell surface protein disulfide isomerases.
    Kung PH; Hsieh PW; Lin YT; Lee JH; Chen IH; Wu CC
    Redox Biol; 2017 Oct; 13():266-277. PubMed ID: 28600983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein disulfide isomerase.
    Wilkinson B; Gilbert HF
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):35-44. PubMed ID: 15158710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.